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Absence of antinatriferic and natriuretic activity in ultrafiltrates
(mol wt less than 50,000) and dialysates from volume-expanded
dogs. Experiments have been carried out to find out if the anti-
natriferic and natriuretic activity present in the blood of volume-
expanded animals is dialyzable or ultrafilterable. Ultrafiltrates
of plasma obtained in vitro, or in vivo, with a 10,000 mol wt cut-
off filter, from saline-loaded dogs produced no consistent effect
on the short circuit current of toad bladder or frog skin. Ex-
tracts of dialysates obtained from large volumes of plasma from
blood of volume-expanded dogs, and extracts of ultrafiltrates
obtained from the plasma of saline-loaded dogs, using 10,000
and 50,000 mol wt cut-off filters, did not produce a natriuresis in
water-loaded rats. It is concluded that the antinatriferic and
natriuretic activity which is present in the blood of volume-
expanded animals is not dialyzable or ultrafilterable under the
conditions described.
Absence d'activité antinatriferrique et natriurétique dans les
ultrafiltrats (PM inférieur a 50,000) et les dialysats de chiens
ayant subi tine expansion. Ce travail a etC rCalisé afin d'établir si
l'activitC antinatriferrique et natriurCtique prCsente dans le sang
d'animaux ayant subi une expansion est dialysable ou ultra-
filtrable. Des ultrafiltrats de plasma obtenus in vitro ou in vivo
avec un filtre dont Ia limite en PM est de 10,000, a partir de
chiens ayant subi une expansion avec du solute sale, ne produi-
sent pas d'effets nets sur le courant de court circuit de Ia vessie
de crapaud ou de Ia peau de grenouille. Des extraits de dialysats
obtenus a partir de volumes importants de plasma sCparC du
sang d'animaux ayant subi une expansion du volume sanguin et
des extraits d'ultrafiltrats obtenus a partir du plasma de chiens
ayant subi une expansion avec du solute sale et au moyen de
filtres a 10,000 et 50,000 de limite en PM, ne produisent pas de
natriurCse chez les rats charges en eau. II est conclu que l'activitC
antinatriferrique et natriurétique qui existe dans le sang des
animaux ayant subi une expansion n'est pas dialysable ou ultra-
filtrable dans les conditions dCcrites.
There is increasing evidence that the natriuresis
caused by volume expansion with blood or saline is
due in part to a circulating antinatriferic and natriure-
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tic substance [1—12]. One group of workers has
claimed that this substance is dialyzable and ultra-
filterable [13—17]. The following experiments were per-
formed in an attempt to confirm and extend this work.
Methods
In vivo preparation of dialysates from blood of dogs
obtained before and after blood volume expansion.
Eight dogs weighing 15 to 32 kg were given supple-
mentary sodium and potassium (sodium, 140 mEq/day
as "Slow Sodium" [CIBA]; and potassium, 48 mEq/
day as "Slow K" [CIBA]) and 5 mg/day of desoxy-
corticosterone acetate (DOCA) for three days prior to
the experiment. The dogs were anesthetized with
30 mg/kg of pentobarbitone. The trachea was intu-
bated and a catheter placed in the bladder.
The femoral artery or both jugular veins were con-
nected to a dialyzer and a siliconized exchange circula-
tion blood reservoir. The reservoir initially contained
2.8% albumin (Bovine Albumin powder, Armour
Pharmaceutical Co. Ltd.) in Hartmann's solution. The
blood circulated at 100 to 170 mi/mm through the
dialyzer and then through the reservoir which was
kept at 39°C.
In three experiments a Kiil dialyzer with a cupro-
phane membrane (PT15O) was used, whereas in the
other five experiments the dialyzer consisted of cellu-
lose acetate hollow fibers (Cordis-Dow Corporation).
The dialysis fluid was Hartmann's solution. The fluid
in the dialysis compartment of the Kiil dialyzer was
static whereas the fluid in the Cordis-Dow dialyzer was
continuously circulated in and out of a reservoir. The
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volume of the dialysis fluid was kept constant in both
sets of experiments.
After a period of 32 to 115 mm of exchange circula-
tion to equilibrate the fluid in the reservoir with the
blood of the dog, the Hartmann's solution was re-
newed, and the control period begun. Dialysate was
collected after 60 to 90 mm and the dialysis compart-
ment refilled with fresh dialysis solution. The blood
volume of the dog was then expanded in 15 mm with
an infusion of 28 mI/kg of equilibrated blood from the
reservoir. Dialysate was collected for 60 to 90 mm after
the start of volume expansion. Extracts of these dialy-
sates were prepared (see following) and injected into
rats. Urine was collected at 20-mm intervals.
In vivo preparation of ultrafiltates of jugular venous
blood of dogs before and during an infusion of saline.
Nineteen dogs weighing 18 to 35 kg were anesthetized
with pentobarbitone (30 mg/kg). The bladder was
catheterized and the femoral and jugular veins cannu-
lated. The blood from the jugular veins was pumped
through an ultrafilter at a rate of 200 to 300 ml/min,
and returned via the femoral veins. Amicon HIDP 10
and HIDPX 50 filters (Amicon Corporation), selective
for mol wts below 10,000 and 50,000, respectively, were
held in a modified adaptor (Dialfilter, Model DH4)
from which the porous polypropylene blood filters had
been removed. Heparin was given i.v., 5,000 U initially,
and 1,000 U/hr thereafter. Ultrafiltrate was collected
into an iced container. At two-mm intervals throughout
the control and experimental periods, the volumes of
ultrafiltrate produced and urine excreted were mea-
sured and an equal volume of saline was administered
i.v. Urine was collected at 20-mm intervals. The con-
trol period varied between 30 and 79 mm, during which
146 to 450 ml of ultrafiltrate was collected. One hun-
dred ml of saline/kg was then infused i.v. in 100 mm,
25% of which was given in the first 15 mm, and the
remainder in the following 75 mi Ultrafiltrate, 180 to
695 ml, was collected during the last 20 to 33 mm of the
saline infusion.
The ultrafiltrates obtained during the control and
experimental periods were tested for their effect on
short current circuit across the frog skin or toad
bladder, and extracts of the ultrafiltrates were injected
into rats to study their effect on sodium excretion.
In vitro preparation of ultrafiltrates of blood obtained
from the jugular veins of dogs before and after an infu-
sion of saline. Twelve mongrel dogs weighing 10 to
20 kg were deprived of food and water for 12 to 18 hr
before they were anesthetized with pentobarbitone
(25 to 35 mg/kg). The bladder was catheterized and a
cannula placed into a foreleg vein for the administra-
tion of saline. Twenty ml of heparinized plasma from
jugular venous blood was centrifuged at 1000 x g for
10 mm, and stored at 4°C. An i.v. infusion of saline
was given for 60 to 90 mm, at a rate of 25 ml/min for
20 mm, and then at 10 ml/min. A second sample of
heparinized plasma from jugular venous blood was
then obtained. Urine was collected at 20-mm inter-
vals.
The protein, sodium and potassium concentrations
of the two samples of plasma were determined. The
protein concentration of the control plasma was then
diluted to that of the expanded plasma with a solution
containing sodium and potassium so that the final
concentrations of these ions in the two plasma samples
were the same. Ten to 12 ml of each of the adjusted
samples of plasma was then ultrafiltered simultane-
ously in two stirred cells (Amicon Model 12) according
to the method of Buckalew [13]. Membranes with
mol wt cut-off 10,000 (Amicon PM 10) were used with
nitrogen at 50 lb/in2 (psi) as the pressure source. The
polypropylene membrane support of each cell had
been replaced with one of stainless steel mesh. The
stirring speed of the magnetic stirring unit in each cell
was adjusted to 1200 rpm with a stroboscope [14].
Ultrafiltration was carried out at + 1°C and the
ultrafiltrates were frozen to —20°C immediately after
collection. They were kept at —20°C until tested. All
the glassware with which the plasma or the ultra-
filtrates came into contact was siliconized. The
ultrafiltrates were tested for their effect on short
circuit current across the isolated frog skin or toad
bladder.
Preparation of extracts from dialysates and ultra-
filtrates obtained in vivo. In each experiment extracts
were made from equal volumes of pre- and postexpan-
sion dialysates or ultrafiltrates. Ultrafiltrates and
dialysates (180 to 695 ml) were obtained and lyophi-
lized in a bulk centrifugal freeze drier (Edward's
Model EF6). The freeze-dried ultrafiltrate or dialysate
was extracted with 15 to 20 ml of 0.1 M acetic acid and
the insoluble residue separated in a refrigerated centri-
fuge (Sorvall). The supernatant was applied to a
column (2.5 x 90 cm) packed with Sephadex G50 m
equilibrated with 0.1 M acetic acid, and was eluted with
0.1 M acetic acid at 40 mi/hr. Optical density was
monitored at 254 m. All eluate up to the salt peak
was collected and freeze-dried. This freeze-dried de-
salted extract was stored at —20°C. On the day of
assay the extract was dissolved in 1.1 to 1.2 ml of a
solution containing NaCl, 10 mEq/liter, and dextrose,
50 g/liter. This solution was also injected i.v. as a
blank into control rats. The protein content of the
dissolved extract was measured by the method of
Lowry et al [18].
Assay of natriuretic activity in the rat. The assays
were performed in 216 unanesthetized male Wistar
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rats, with a mean weight of 121 g (86 to 153 g) infused
with hypotonic dextrose saline in the manner de-
scribed by Brown, Koutsaimanis and de Wardener
[19]. The persons involved in the assay did not know
the identity of the extracts. The i.v. priming infusion
contained 20 mEq of NaCl and 50 g of dextrose/liter.
The maintenance infusion given at 0.2 mi/mm con-
tained 10 mEq of NaC1 and 50 g of dextrose/liter. The
urine was collected in 10-mm periods. The i.v. injec-
tions of the extracts and of the blanks were given with-
in 10 mm at the same rate as the maintenance infusion,
which they interrupted. The mean urinary sodium ex-
cretion of the four control urine collection periods
before the i.v. injections was compared with the mean
sodium excretion of the eight subsequent collection
periods. Rats in which the mean urinary sodium excre-
tion during the four control periods was below 1 Eq/
mm were excluded. When the extracts or blanks were
tested on more than one rat, the mean results were
used.
Assay of antinatriferic activity in the frog skin and
toad bladder. Ultrafiltrates were tested for their effect
on the short circuit current of the skin of Rana tern-
poraria or the bladder of Bufo marinus. The persons
involved in these tests did not know the identity of the
extracts, The toads were obtained from The Pet Farm,
Miami, Florida. Animals were maintained on distilled
water for at least three days before use.
Membranes were mounted in two perspex chambers,
each of lO-ml capacity. They were filled with Ringer's
solution aerated with 3% CO2 in 02. For each experi-
ment two half-skins or hemibladders, each with an
area of 5 cm2, were used. The ultrafiltrates were tested
on one membrane (the test membrane); the other
served as a control (the control membrane). The short
circuit current was measured by the method described by
Nutbourne [20]. Measurements were made at five-mm
intervals after the current had been applied for two mm.
Samples were tested only when the difference in short
circuit current between the two membranes had not
altered by more than 5% during a control period of
30 mm, and when the potential difference and short
circuit current of each membrane was greater than
20 my and 80 LA, respectively. Experiments in which
the control membrane altered by more than 5% during
the test period were discarded.
Ultrafiltrates were diluted to the osmolality, and
warmed to the temperature, of the Ringer's solution in
contact with the membranes during the control period.
Three % CO2 in 02 was bubbled through the
diluted warmed ultrafiltrate for 5 to 15 mm before
before being placed in the membrane chamber. The
concentrations of sodium, potassium and calcium and
the pH of the ultrafiltrates and of the Ringer's solu-
tions estimated at the end of the experiments did not
differ significantly.
In experiments 9 through 19, the Ringer's solution
contained the following: NaCI, 83.0 mM; NaHCO3,
17.0 mM; Na2HPO4, 2.5 mM; KH2PO4, 0.5 mM;
CaCI2, 1.0 ifiM KCI, 2.5 mM; and glucose, 100 mgI
100 ml. initially, 5 ml of Ringer's solution was placed
on each side of the membranes. Subsequently, at 15-
mm intervals throughout the experiment, fresh
Ringer's was flushed through alternate sides of both
test and control membranes. Care was taken to avoid
disturbing the membrane during this procedure by
allowing 10 ml of Ringer's to run in at the top of the
chamber at the same rate as it was withdrawn from the
bottom. When the short circuit current had been stable
for 30 mm, the solution on the serosal side of the test
membrane was flushed through with ultrafiltrate in-
stead of Ringer's solution. The 12 ultrafiltrates from
experiments 9 through 14 were tested on frog skin, and
the 10 ultrafiltrates from experiments 15 through 19 on
toad bladder.
In experiments 20 through 26, the Ringer's solution
contained NaCl, 110.0 mM; KCI, 2.5mM; CaCI2,
1.0 mM; NaHCO3, 15.0 mM; and glucose 100 mg/
100 ml. This solution was continuously recirculated at
approximately 3 mi/mm through both sides of the two
membrane chambers. Each had a reservoir common to
both sides of the membranes. The volume of solution
in circulation was changed every 30 mm. At the end of
the 30 mm of the control period, the prepared ultra-
filtrate was substituted for fresh Ringer's, so that the
ultrafiltrate bathed both sides of the membrane.
Thirteen ultrafiltrates from experiments 20 through 26
were tested on nine frog skins and four toad blad-
ders.
The short circuit current reading 30 mm after addi-
tion of the ultraflitrate to the test membrane was used
to calculate percentage change in short circuit current,
using the following formula:
(A—B)—(C—D)x 100,C
where C and D are the mean short circuit currents of
test and control membranes, respectively, during the
30-mm control period, and A and B are corresponding
readings of the short circuit current 30 mm after
Ringer's solution had been replaced by ultrafiltrate on
the test membrane.
Sodium and potassium were measured on an iL
flame photometer, calcium on an Eppendorf flame
photometer and pH on a pH meter (Pye model 290).
Osmolality was measured by freezing point depression
on an osmometer (Advanced). The results were
assessed using Student's unpaired t test,
Properties of transport inhibitory factor in plasma 391
Table 1. Effect on rat urinary sodium excretion of extracts of dialysates obtained in vivo from jugular venous blood of dogs, before and
after saline infusiona
Experi-
ment
No.
Pre-expansion dialysates Postexpansion dialysates Dextrose saline
UV, Eq/min
Rats
UNaY, zEq/min
Rats
UNOV, Eq/min
Before After tRats Before After Before After
N injection injection N injection injection N injection injection
1 2 3.98 3.50 —0.48 3 3.25 3.64 +0.39 — — — —
2 3 2.99 2.64 —0.35 3 4.39 3.14 —1.25 — — — —
3 3 2.67 3.41 +0.74 3 1.80 3.10 + 1.30 — — — —
4 1 2.95 2.87 —0.08 1 2.32 2.82 +0.50 1 2.30 3.30 +1.00
5 3 2.32 2.41 +0.09 2 1.15 1.54 +0.39 2 1.36 1.93 +0.57
6 3 3.51 4.40 +0.89 3 4.27 3.57 —0.70 2 4.68 6.41 + 1.73
7 2 4.36 3.85 —0.51 3 4.69 4.43 —0.26
8 3 3.08 3.52 +0.44
+0.18±0.49
3 2.47 2.54 +0.07
+0.02±0
2 1.89 2.64 +0.75
+0.76±0.99
a Average difference: pre-expansion dialysates vs. postexpansion dialysates= —0.16, t=0.432, 2P=0.7; pre-expansion dialysates vs.
dextrose saline=0.58, 1= — 1.615, 2P=0.2; postexpansion dialysates vs. dextrose saline=0.74, t= — 1.659, 2P0.2.
Results
Extracts of dialysates. The effect of concentrated
extracts of dialysates obtained in vivo from the blood of
dogs, before and after blood volume expansion on the
urinary sodium excretion of the rat (Table 1). The
protein content of the solutions of extracts injected
into the rats varied from 0.33 to 0.45 mg/mi. There
was a mean rise in urinary sodium excretion of
0.18 Eq/min in the rats given the dialysate extract
obtained before blood volume expansion, and a mean
rise of 0.2 1iEq/min in the rats given the extract ob-
tained after blood volume expansion. The change in
urinary sodium excretion in the rat given the glucose
saline blank was 0.76 Eq/min. None of the changes
was significant, and there was no significant difference
between the three groups.
Extracts of in vivo ultrafiltrates. 1) Effect on the
urinary sodium excretion of the rat of concentrated ex-
tracts of ultrafiltrates prepared in vivo from the blood of
dogs before and after infusion of saline, using filters
selective for niol wts a) less than 10,000 and b) less than
50,000 (Table 2). The protein content of the extracts
obtained with the 10,000 mol wt filters varied from
0.25 to 0.63 mg/ml, and those obtained with the
50,000 mol wt filters varied from 1.2 to 24.0 mg/mI.
Neither extract had a consistent effect on urinary
sodium excretion in the rat.
2) Effect on the short circuit current across the frog
skin or toad bladder of ultrafiltrates prepared in vivo
from the blood of dogs before and after infusion of saline
using a filter selective for mol wts less than 10,000
(Table 3). The ultrafiltrates had no consistent effect on
short circuit current across the frog skin or toad
bladder.
In vitro ultrafiltrates. Effect on the frog skin and toad
bladder of ultrafiltrates prepared in vitro from the
jugular venous blood of dogs obtained before and after
infusion of saline (Table 4). Ultrafiltrates obtained be-
fore the administration of saline caused a mean change
of —0.33% in the short circuit current of the frog
skin, and those obtained after the administration of
saline caused a mean change of + 1.33%.
When tested on the toad bladder, ultrafiltrates
obtained before the administration of saline caused a
mean change of —0.20% in the short circuit current,
while those obtained subsequently caused a mean
change of —2.00%. The difference between these re-
sults was not statistically significant.
Discussion
The results demonstrate that with the techniques
used the antinatriferic and natriuretic activity of the
plasma in these volume-expanded animals was not
dialyzable or ultrafilterable. Though the plasma was
not tested for natriuretic activity before being dialyzed
and ultrafiltered, the methods used to expand the body
fluids of the dogs were the same as those used in ex-
periments in which the blood has developed antinatri-
feric and natriuretic properties [2—12], and in the ex-
periments described here they caused a substantial rise
in urinary sodium excretion in dogs.
The original aim of this study was to test for natri-
uretic activity in concentrated salt-free extracts pre-
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Ta',le 2. Effect on rat urinary sodium excretion of extracts of ultrafiltrates prepared in vivo from blood taken from dogs before and
after infusion of saline using filters selective for mol wt (A) less than 10,000a and (B) less than 50,000b
Experi-
mnt
No.
Pre-expansion ultraflitrates Postexpansion ultrafiltrates
—
Dextrose saline
UNaY, Eq/min UNaV, .Eq/min
Rats
UNaV, p.Eq/min
Rats Before After Rats Before After Before After
N injection injection N injection injection N injection injection
(A) mol wt <10,000
28 —-. -—- — — 2 1.62 1.76 +0.14 2 2.05 2.16 +0.11
29 — — — — 4 2.27 3.48 + 1.21 2 2.58 2.19 —0.39
30 — — — 2 2.02 2.67 +0.65 3 2.46 2.91 +0.45
31 3 3.62 3.02 —0.60 3 4.68 3.61 —1.07 2 3.09 2.41 —0.68
32 2 2.06 2.28 +0.22 3 2.21 2.35 +0.14 2 1.74 2.43 +0.69
—0.19±0.4! +0.21±0.76 +0.04±0.53
33 — —- — —
(B) mol wt <50,000
2 1.62 3.60 + 1.98 2 1.76 2.44 +0.68
34 2 1.91 2.85 +0.94 3 1.88 2.33 +0.45 1 2.92 3.18 +0.26
35 3 3.46 3.55 +0.09 3 2.90 3.94 +1.04 2 3.77 3.15 +0.62
36 2 3.31 4.44 + 1.13 — — — 3 2.07 1.81 —0.26
37 3 292 4.20 +1.28 3 2,99 4.05 +1.06 1 2.66 3.71 +1.05
38 3 3.05 3.19 +0.14 3 4.93 4.94 +0.01 1 2.82 3.99 + 1.17
39 3 2.33 3.66 + 1.33 3 2.60 2.32 —0.28 2 1.77 2.09 +0.32
+0.82±0.51 +0.71±0.75 +0.55±0.44
Average difference: postexpansion ultrafiltrates vs. dextrose saline —0.17, t = 0.39, 2P <0.7.
b Average difference: pre-expansion ultrafiltrates vs. postexpansion ultrafiltrates = —0.11, t =0.26, 2P <0.9; pre-expansion ultrafiltrates
vs. dextrose saline= —0.27, t=0.91, 2P <0.4; postexpansion ultrafiltrates vs. dextrose saline= —0.16, t=0.44, 2P< 0.6.
pared from large volumes of dialysates or ultrafiltrates
obtained from volume-expanded dogs. The technique
used to desalt the dialysates and ultrafiltrates was that
used in a previous study [191 in which extracts were
prepared from the urine of salt-loaded individuals.
These urine extracts were shown to be natriuretic, and
these findings confirmed the work of Sealey, Kirsh-
mann and Laragh [4]. The extracts described here
which were prepared from as much as 180 to 695mlof
plasma dialysate or ultrafiltrate were not natriuretic in
Table 3. Effect on short circuit current across frog skin or toad bladder of ultrafiltrates prepared in vivo from blood of dogs before and
after saline infusion, using filters selective for mol wt less than l0,000.l
Experiment
No.
Pre-expansion ultrafiltrates Postexpansion ultrafiltrates
CA A-BA C-DA (A-B)—(C-)C 100'<
C
A
A-B
A
C-DA (A-B)—(C-D)c xlOO
0/; 0/;
20 — — — — 150 —62 —48 —9
21 114 +7 +6 +1 212 —4 —1 —1
22 141 +4 +12 —6 125 +37 +49 —10
23 130 —15 —4 —8 109 +31 +30 +1
24 203 —19 —32 +6 91 —23 —22 —l
25 178 +10 +13 —2 112 —1 +6 —6
26 168 —2 +20 —13 96 —5 —10 +5
—3,67±6.77 —3.00±5.50
a C and D are the mean short circuit current of the test and control membranes, respectively, during the control period. A and B are
the short circuit current of test and control membranes, 30 mm after Ringer's solution had been replaced by ultrafiltrate on the test
membrane.
b Average difference: pre-expansion ultrafiltrates vs. postexpansion ultrafiltrates = —0.67 A, t =0.196, 2P <0.9.
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Table 4. Effect on short circuit current across frog skin or toad bladder of ultrafiltrates prepared in vitro from jugular venous blood of
dogs, obtained before and after saline infusion b
Experiment
No.
Pre-expansion ultrafiltrates Postexpansion ultrafiltrates
CA A-BtA C-DA (A-B)—(C-D) 100C X
C
tA
A-BA C—DA (A-B)--(c--D)C xlOO
Frog skin
9 122 +25 +26 —1 88 +7 +1 +7
10 98 +2 —10 +12 95 +17 +15 +2
11 123 +1 +21 —16 96 —21 —25 +4
12 94 +10 +3 +7 135 +3 +6 —2
13 99 —5 —9 +4 115 —5 —8 +3
14 86 —15 —7 —8 90 —13 —8 —6
—0.33±10.28
Toad bladder
15 221 +108 +136 —13 195 +96 +96 0
16 129 +32 +14 +14 143 +43 +43 0
17 198 +101 +117 —8 206 +116 +119 —1
18 169 +82 +77 +3 154 +83 +83 0
19 153 +56 +51 +3 184 +22 +39 —9
—0.20±17.56 —2.00± 3.93
C and D are the mean short circuit current of test and control membranes, respectively, during the control period. A and B are the
short circuit current of test and control membranes 30 mm after Ringer's solution had been replaced by ultrafiltrate on the test
membrane.
b Average difference between pre- and postexpansion ultrafiltrates = —1.66sA for the frog skin experiments (t= —0.362, 2P <0.8) and
—1.80 A for the toad bladder experiments (t=0.357, 2P<0.8).
the rat. These extracts would theoretically have con-
tained substances with mol wts between 50,000 and
1500. If the mol wt of the antinatriferic, natriuretic
substance is less than 1500, it would clearly have been
removed during the gel filtration procedure. However,
the dialysates and ultrafiltrates included substances
with mol wts below 1500 and they were without effect
on short circuit current across the frog skin or toad
bladder. These findings are in line with those of Rector
et al [21], who at first claimed that the natriuretic prop-
erty of plasma obtained from volume-expanded
animals is dialyzable, but subsequently found it im-
possible to obtain consistent results (F. C. Rector,
personal communication). Moreover, Wright et a! [22]
repeated the experiments and were also unable to con-
firm the original findings. In addition Sealey, Kirshman
and Laragh [4] were not able to dialyze the natriuretic
material from the plasma and urine of volume-
expanded animals. Viskoper et al [23] and Kruck [24]
also found that the natriuretic material obtained from
the urine of salt-loaded man remained within the
dialyzing membrane; but they did not test the dialysate
for natriuretic activity.
Buckalew's group [13—17] claims that the plasma
from volume-expanded animals contains an antinatri-
feric and natriuretic substance which is ultrafilterable.
They [13, 17] prepared in vitro ultrafiltrates from
jugular venous blood of dogs expanded with saline,
using stirred pressure cells with membranes which
allowed passage of substances with a mol wt less than
approximately 10,000. The effect of these ultrafiltrates
was tested on the short circuit current of the toad
bladder and the frog skin. Certain details of the ultra-
filtration technique [7] were elaborated in a further
paper [14]. It was claimed that the antinatriferic activ-
ity was adsorbed onto the polypropylene membrane
support of the stirred cell, and that the amount of anti-
natriferic activity obtained was dependent on the stir-
ring speed. To obtain the maximum amount of anti-
natriferic activity, it was recommended that stainless
steel mesh should be substituted for the polypropylene
membrane support and that the stirring speed should
be approximately 1200 rpm.
In the third group of experiments described here, we
endeavored to repeat Buckalew's experimental tech-
nique [13, 14, 17]. The dogs were of similar weight and
sex, the infusion rate of saline and the quantity given
were the same. Jugular venous blood plasma was
ultrafiltered in the same model of stirred cell with the
same filters (Amicon) on stainless steel supports. Be-
fore ultrafiltration the protein content of the control
plasma was diluted to that of the experimental plasma,
an adjustment not mentioned by Buckalew. The stir-
ring speed, the collection of the ultrafiltrate into dry ice
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and the ultrafiltration pressure source of N2, 50 lb/in2
(psi), were as described by Buckalew et al [13, 14, 17].
Ultrafiltration was carried out at a temperature 3°C
lower than that in Buckalew's experiments [14]. Our
ultrafiltrates were kept at —20°C until the day of
assay; Buckalew's were stored at —4°C.
The toads on which the ultrafiltrates were assayed
were the same as those of Buckalew's group [13, 14, 17],
but whereas Buckalew and Nelson [17] used Rana
pipiens, we used Rana temporaria. The minimum milli-
volts, and short circuit current above which the mem-
brane was considered suitable for an assay, and the
duration of the stable baseline before the assay were
the same as those of Buckalew. The Ringer's solution
was aerated with the same gas and was of identical ionic
composition except that the bicarbonate composition
was lower. This lower concentration was found to be
necessary in order that the pH of the Ringer's and
ultrafiltrate should be the same. Buckalew et al [13, 17]
made no mention of bubbling CO2 through the ultra-
filtrate before assay, and did not state the frequency or
duration of application of the short circuit current. In
the experiments described here, the ultrafiltrates were
equilibrated with 3% CO2 before testing, so that their
pH was the same as that of the Ringer's.
These small differences between our technique and
that of Buckalew et al's are mainly due to our attempts
to ensure that the conditions under which the plasma
samples were ultrafiltered and the ionic concentration
and pH of the ultrafiltrates and Ringer's when they
were applied to the membrane were the same. It is un-
likely that these differences are responsible for the dis-
crepancy between our results and those of Buckalew's
group [13, 14, 17]. It is therefore difficult to understand
why the ultrafiltrates obtained in vitro (or in vivo) from
our saline-loaded dogs were not antinatriferic on the
toad bladder, or on the frog skin. These discrepant re-
suits do not necessarily invalidate those of Buckalew's
group. They demonstrate, however, that an attempt to
obtain an antinatriferic substance with the methods
described by Buckalew's group was unsuccessful.
Buckalew and Nelson [17] have recently prepared
extracts from 10 ml of in vitro plasma ultrafiltrates
which they report are natriuretic in the partially ne-
phrectomized, conscious, water-loaded rat. The 10-ml
aliquots of ultrafiltrate were freeze-dried, dissolved in
7M hydrochloric acid and then gel-filtered on G 10
Sephadex using 0.1 M hydrochloric acid as eluant. The
extracts were prepared from the fraction eluted im-
mediately before the salts. The mol wt of the natriuretic
substance in their extracts was thus likely to be less
than 700. These gel filtration procedures were clearly
different from those described in this study and were
an extension of Buckalew and Nelson's finding that
their ultrafiltrates were antinatriferic. The in vitro
ultrafiltrates described here, which were prepared by
the same technique as Buckalew's group, possessed no
antinatriferic activity. No attempt was made, therefore,
to isolate a natriuretic fraction from these uitrafiltrates.
The results presented here agree with those re-
ported by others [4, 21—24] and suggest that under the
conditions described, the antinatriferic and natriuretic
substance present in the plasma and urine of volume-
expanded animals and man is not dialyzable or ultra-
filtrable.
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